{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-016501","form_type":"8-K","ticker":"PRPH","cik":"0000868278","company_name":"ProPhase Labs, Inc.","filed_at":"2025-06-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.524234+00:00","generated_at":"2026-05-18T21:46:37.125542+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"ProPhase Labs appoints Carolina Abenante as independent director effective June 20, 2025","bullets":["Ms. Abenante will serve on Nominating and Corporate Governance Committee and as Chair of Compensation Committee.","Her term expires July 18, 2025, at the annual meeting; she is nominated for election to a full term.","She will be appointed to the Audit Committee effective July 19, 2025, subject to independence and financial literacy.","Ms. Abenante is founder of NYIAX and holds multiple law degrees; she receives $48,000 annual retainer and equity participation."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-016501","json":"https://secwatch.observer/filing/0001641172-25-016501.json","markdown":"https://secwatch.observer/filing/0001641172-25-016501.md","text":"https://secwatch.observer/filing/0001641172-25-016501.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/868278/000164117225016501/0001641172-25-016501-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/868278/000164117225016501/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T21:46:37.125542+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4791bb37b9","claim":"Carolina Abenante was appointed as independent director at ProPhase Labs, Inc..","evidence_excerpt":"On June 20, 2025, the Board of Directors (the “Board”) of ProPhase Labs, Inc. (the “Company”) appointed Carolina Abenante, Esq. to serve as an independent director to fill the existing vacancy on the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/868278/000164117225016501/0001641172-25-016501-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"independent director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}